Medtronic EBITDA Margin 2010-2024 | MDT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medtronic (MDT) over the last 10 years. The current EBITDA margin for Medtronic as of October 31, 2024 is .
| Medtronic EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-07-31 | $32.58B | $7.79B | 23.92% |
| 2024-04-30 | $32.36B | $7.79B | 24.08% |
| 2024-01-31 | $32.32B | $8.33B | 25.78% |
| 2023-10-31 | $31.96B | $8.27B | 25.88% |
| 2023-07-31 | $31.56B | $8.33B | 26.40% |
| 2023-04-30 | $31.23B | $8.18B | 26.20% |
| 2023-01-31 | $30.77B | $8.30B | 26.96% |
| 2022-10-31 | $30.81B | $8.56B | 27.78% |
| 2022-07-31 | $31.07B | $8.72B | 28.07% |
| 2022-04-30 | $31.69B | $8.46B | 26.70% |
| 2022-01-31 | $31.79B | $8.39B | 26.39% |
| 2021-10-31 | $31.80B | $8.01B | 25.20% |
| 2021-07-31 | $31.60B | $7.37B | 23.34% |
| 2021-04-30 | $30.12B | $7.19B | 23.86% |
| 2021-01-31 | $27.93B | $5.89B | 21.08% |
| 2020-10-31 | $27.87B | $6.23B | 22.37% |
| 2020-07-31 | $27.93B | $6.65B | 23.83% |
| 2020-04-30 | $28.91B | $7.45B | 25.78% |
| 2020-01-31 | $31.06B | $9.08B | 29.23% |
| 2019-10-31 | $30.89B | $8.99B | 29.12% |
| 2019-07-31 | $30.67B | $9.17B | 29.89% |
| 2019-04-30 | $30.56B | $8.93B | 29.21% |
| 2019-01-31 | $30.56B | $8.91B | 29.15% |
| 2018-10-31 | $30.38B | $8.79B | 28.94% |
| 2018-07-31 | $29.95B | $9.17B | 30.61% |
| 2018-04-30 | $29.95B | $9.28B | 31.00% |
| 2018-01-31 | $29.73B | $9.07B | 30.52% |
| 2017-10-31 | $29.64B | $8.86B | 29.88% |
| 2017-07-31 | $29.93B | $8.41B | 28.09% |
| 2017-04-30 | $29.71B | $8.30B | 27.94% |
| 2017-01-31 | $29.36B | $8.21B | 27.96% |
| 2016-10-31 | $29.01B | $8.40B | 28.96% |
| 2016-07-31 | $28.73B | $8.28B | 28.83% |
| 2016-04-30 | $28.83B | $8.21B | 28.47% |
| 2016-01-31 | $28.57B | $6.76B | 23.67% |
| 2015-10-31 | $25.95B | $6.24B | 24.03% |
| 2015-07-31 | $23.26B | $5.63B | 24.22% |
| 2015-04-30 | $20.26B | $5.15B | 25.41% |
| 2015-01-31 | $17.52B | $4.83B | 27.55% |
| 2014-10-31 | $17.37B | $4.52B | 26.01% |
| 2014-07-31 | $17.20B | $4.54B | 26.39% |
| 2014-04-30 | $17.01B | $4.67B | 27.47% |
| 2014-01-31 | $16.90B | $5.58B | 33.04% |
| 2013-10-31 | $16.76B | $5.80B | 34.59% |
| 2013-07-31 | $16.67B | $5.79B | 34.71% |
| 2013-04-30 | $16.59B | $5.68B | 34.23% |
| 2013-01-31 | $16.43B | $5.68B | 34.58% |
| 2012-10-31 | $16.32B | $5.61B | 34.37% |
| 2012-07-31 | $16.25B | $5.66B | 34.81% |
| 2012-04-30 | $16.18B | $5.67B | 35.01% |
| 2012-01-31 | $15.86B | $5.47B | 34.45% |
| 2011-10-31 | $15.80B | $5.46B | 34.57% |
| 2011-07-31 | $15.68B | $5.35B | 34.14% |
| 2011-04-30 | $15.51B | $5.27B | 34.00% |
| 2011-01-31 | $15.30B | $5.34B | 34.90% |
| 2010-10-31 | $15.30B | $5.46B | 35.71% |
| 2010-07-31 | $15.23B | $5.56B | 36.53% |
| 2010-04-30 | $15.39B | $5.65B | 36.73% |
| 2010-01-31 | $15.45B | $5.23B | 33.82% |
| 2009-10-31 | $15.09B | $4.91B | 32.54% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $109.010B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
| Stryker (SYK) | United States | $148.171B | 33.39 |
| Boston Scientific (BSX) | United States | $133.131B | 38.28 |
| EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
| ResMed (RMD) | United States | $34.955B | 28.72 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
| Insulet (PODD) | United States | $18.377B | 73.18 |
| Baxter (BAX) | United States | $16.604B | 10.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
| Bio-Rad Laboratories (BIO) | United States | $8.977B | 30.51 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
| TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
| Haemonetics (HAE) | United States | $4.260B | 20.79 |
| ICU Medical (ICUI) | United States | $4.155B | 39.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
| Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
| Envista Holdings (NVST) | United States | $3.487B | 25.97 |
| Neogen (NEOG) | United States | $3.270B | 37.72 |
| Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
| QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
| Warby Parker (WRBY) | United States | $2.344B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.332B | 56.69 |
| Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
| AtriCure (ATRC) | United States | $1.772B | 0.00 |
| InMode (INMD) | Israel | $1.487B | 8.94 |
| Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.957B | 7.48 |
| CeriBell (CBLL) | United States | $0.916B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
| Capricor Therapeutics (CAPR) | United States | $0.839B | 0.00 |
| Evolus (EOLS) | United States | $0.785B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
| Surmodics (SRDX) | United States | $0.559B | 0.00 |
| Quanterix (QTRX) | United States | $0.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
| Valneva SE (VALN) | France | $0.370B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.63 |
| Omeros (OMER) | United States | $0.349B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
| Biote (BTMD) | United States | $0.330B | 7.25 |
| Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
| Zynex (ZYXI) | United States | $0.249B | 52.13 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
| Jin Medical (ZJYL) | China | $0.188B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.70 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
| TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 10.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| Exagen (XGN) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.17 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |